Literature DB >> 18372221

Genotype determination in Moroccan hepatitis B chronic carriers.

Sayeh Ezzikouri1, Isabelle Chemin, Abdelaziz Chafik, Lahsen Wakrim, Jalal Nourlil, Abdelouhad El Malki, Agnès Marchio, Anne Dejean, Mohammed Hassar, Christian Trepo, Pascal Pineau, Soumaya Benjelloun.   

Abstract

BACKGROUND: In Morocco, chronic liver disease related to hepatitis B virus (HBV) is a public health burden. Treatment of chronic hepatitis B is often complicated by the appearance of escape mutants after treatment with nucleoside analogs, especially with genotypes responsible for the more severe form of the disease.
OBJECTIVES: In the present study we investigate the prevalence of the different HBV genotypes in Morocco since no previous careful study has been attempted.
METHODS: Epidemiological data from 91 chronically infected patients (45 women and 46 men) were collected prospectively. Sera were tested for anti-HBc IgG, HBeAg, anti-HBe antibody and liver enzymes. Restriction Fragment Length Polymorphism (RFLP) analysis was confirmed by subsequent sequencing of the pre-S and S region of the viral genome in order to determine which HBV genotypes were prevalent among Moroccan patients.
RESULTS: The mean age was 41+/-12.4 years. Ten patients (11%) were positive for hepatitis B e antigen (HBeAg) and 81 (89%) were positive for anti-HBe antibodies. By the RLFP method, genotype D, pattern D2, was found in the 77 cases where HBV was successfully amplified. Phylogenetic analysis based on pre-S/S sequences revealed that genotype D in Morocco differed from others D strains subgenotypes (D1, D2, D3 and D4). In addition, the pre-core mutant defined as HBeAg-negative/anti-HBe-positive and HBV DNA positive was detected in 86% of cases.
CONCLUSIONS: Our results clearly show that genotype D and pre-core mutant are highly prevalent in Morocco.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372221     DOI: 10.1016/j.meegid.2008.01.010

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  11 in total

1.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

2.  Prevalence of Hepatitis B Virus Infection Markers among Patients of the Ibn Sina University Hospital Center (Rabat, Morocco).

Authors:  Mourad Feindiri; Hakima Kabbaj; Mohammed El Mzibri; Bouchra Belkadi; Najat Bouihat; Abdelkarim Filali-Maltouf; Myriam Seffar
Journal:  Intervirology       Date:  2021-09-10       Impact factor: 2.294

3.  Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia.

Authors:  Naila Hannachi; Nadia Ben Fredj; Olfa Bahri; Vincent Thibault; Asma Ferjani; Jawhar Gharbi; Henda Triki; Jalel Boukadida
Journal:  Virol J       Date:  2010-11-04       Impact factor: 4.099

4.  Viral hepatitis a to e in South mediterranean countries.

Authors:  Sanaa M Kamal; Sara Mahmoud; Tamer Hafez; Runia El-Fouly
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-02-10       Impact factor: 2.576

5.  Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana.

Authors:  Kobina Assan Ampah; Carlos Augusto Pinho-Nascimento; Sarah Kerber; Prince Asare; Daniel De-Graft; Frank Adu-Nti; Izabel C N P Paixão; Christian Niel; Dorothy Yeboah-Manu; Gerd Pluschke; Katharina Röltgen
Journal:  PLoS One       Date:  2016-06-06       Impact factor: 3.240

6.  [Seroprevalence of HBsAg in pregnant women in central Morocco].

Authors:  Mohammed Sbiti; Hanane Khalki; Imane Benbella; Lhoussaine Louzi
Journal:  Pan Afr Med J       Date:  2016-07-01

7.  Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression.

Authors:  Bouchra Kitab; Abdellah Essaid El Feydi; Rajaa Afifi; Christian Trepo; Mustapha Benazzouz; Wafaa Essamri; Fabien Zoulim; Isabelle Chemin; Hanane Salih Alj; Sayeh Ezzikouri; Soumaya Benjelloun
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

8.  HBV Subgenotypes D1, D2, D-del! Are 'Old' Genotyping Methods Interpreted Correctly?

Authors:  Samad Amini-Bavil-Olyaee; Frank Tacke; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-07-01       Impact factor: 0.660

9.  Evaluation of PCR-RFLP in the Pre-S Region as Molecular Method for Hepatitis B Virus Genotyping.

Authors:  Rim Ouneissa; Olfa Bahri; Ahlem Ben Yahia; Henda Touzi; Mohamed Msaddak Azouz; Nabyl Ben Mami; Henda Triki
Journal:  Hepat Mon       Date:  2013-10-15       Impact factor: 0.660

Review 10.  A review of the infection-associated cancers in North African countries.

Authors:  Wafaa Mohamed Hussein; Wagida A Anwar; Mohammed Attaleb; Loubna Mazini; Asta Försti; Roxana-Delia Trimbitas; Meriem Khyatti
Journal:  Infect Agent Cancer       Date:  2016-08-10       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.